US Capital Global Engaged by QT Ultrasound as Strategic Advisor for $10MM Capital Formation

QT Ultrasound

Global private financial group headquartered in San Francisco engaged by privately held MedTech company as strategic advisor.

SAN FRANCISCO, NOVEMBER 2020 – US Capital Global has been retained by QT Ultrasound® as its strategic advisor for a $10 million capital formation. QT Ultrasound is a California-based technology company engaged in developing and commercializing its QT Ultrasound Breast Scanner, an innovative automated breast imaging system that produces high-resolution transmission ultrasound images.

Approximately 39 million women in the United States get mammograms each year. For every woman with cancer, 19 more will be told they might have cancer when they in fact do not. The resulting cost, time, and psychological distress take an enormous toll. QT Ultrasound aims to revolutionize breast imaging with its QT Ultrasound Breast Scanner, which has FDA 510(K) clearance as an adjunct to mammography.

Headquartered in San Francisco, US Capital Global is a full-service private financial group with an established track record in investment banking, asset management, and capital formation services. The firm provides sophisticated debt, equity, and investment products to lower middle market companies and investors. All securities are offered by the group through its FINRA-member, SEC-registered broker-dealer affiliate, US Capital Global Securities LLC.

Dr. John Klock, M.D., CEO and Founder of QT Ultrasound, said: “We are currently at an inflection point in the growth of our business, as we advance our QT Ultrasound Breast Scanner, expand our FDA clearances, and bring the device to market. We are very thankful to be supported by the US Capital Global, team, which has a long history of advising and funding companies in the healthcare industry, especially in the medical device sector.”

“We are very excited to begin working with Dr. Klock and his experienced team at QT Ultrasound,” said Jeffrey Sweeney, Chairman and CEO at US Capital Global. “Healthcare is an industry that can come with larger overheads and requires significantly higher levels of capital expenditure. Structuring and securing the right debt or equity business financing is therefore essential. We look forward to supporting QT Ultrasound’s continued growth as the company’s strategic advisor for this $10 million capital formation.”

About QT Ultrasound LLC

QT Ultrasound® is a privately held company engaged in the research, development, and commercialization of an innovative automated imaging system producing high-resolution transmission ultrasound images. The company has received FDA 510(K) clearance for its QT Ultrasound Breast Scanner, and the National Institutes of Health (NIH) awarded over $15 million in funding to continue QT Ultrasound research. The company’s clinical trials have been conducted at prestigious institutions in the US and Europe.

About US Capital Global

Established in 1998, US Capital Globalleverages the latest FinTech and RegTech innovation to provide sophisticated debt, equity, and investment products to lower middle market companies and investors. The US Capital Global group manages direct investment funds and provides wealth management and capital raise services through its affiliates, including US Capital Global Investment Management LLC, US Capital Global Wealth Management LLC, and its FINRA-member, SEC-registered broker-dealer, US Capital Global Securities LLC. The group collaborates closely with its peers in professional banking and investment advisory.

To learn more about US Capital Global, email Jeffrey Sweeney, Chairman and CEO, at or call +1 415-889-1010.

Download a PDF of this Press Release

Sign up to our weekly newsletter

Click here

Contact our Media department

Click here